By Elaine Meyer ( December 4, 2009, 4:14 PM EST) -- Teva Pharmaceuticals USA Inc. has clarified that certain infringement allegations don't target Mylan Inc. in a suit filed against the generics maker, its U.S. manufacturer and Natco Pharma Ltd. over a bid to make a copycat version of Teva's multiple sclerosis drug Copaxone....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.